Savara announces new employment inducement grant

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee. on september 25, 2024, savara's board of directors granted the inducement awards to braden parker, who joined the company as chief commercial officer on september 24, 2024. the inducement awards consist of options to purchase 170,000 shares of the company's common stock and restricted stock.
SVRA Ratings Summary
SVRA Quant Ranking